IGF1R and ovarian cancer: The positivity rate of IGF-1R in ovarian cancer tissues was 93.33%, significantly higher than in borderline tumor (63.33%), benign tumor (53.33%) (P < 0.05), and normal ovarian tissue samples (40%) (P < 0.01).